Response to “Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients”

Response to “Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients”

Bibliographic Details
Main Authors:	Marijke Linschoten, Linda Nab, Iwan C.C. van der Horst, Robert Tieleman, Folkert W. Asselbergs
Format:	Article
Language:	English
Published:	Elsevier 2021-02-01
Series:	International Journal of Infectious Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971220325297

Similar Items

Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients
by: A.J.J. Lammers, et al.
Published: (2020-12-01)

Response to correspondence concerning: “Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients”
by: A.J.J. Lammers, et al.
Published: (2021-02-01)

Chloroquine, hydroxychloroquine and COVID-19
by: Erickson, T. B., et al.
Published: (2020)

Chloroquine and hydroxychloroquine for COVID-19 treatment
by: Dwi Aris Agung Nugrahaningsih, et al.
Published: (2020-05-01)

Chloroquine and hydroxychloroquine in the context of COVID-19
by: Ashutosh M Shukla, et al.
Published: (2020-04-01)

Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
by: Tzu-Chuan Ho, et al.
Published: (2021-02-01)

Nephrotoxicity of Chloroquine and Hydroxychloroquine in COVID-19 Patients
by: Javad Mahmoudi, et al.
Published: (2021-01-01)

Chloroquine, hydroxychloroquine, and COVID-19, the Libyan prospective
by: Abdalla Salem Elhwuegi
Published: (2020-01-01)

Comparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir
by: Rahmet Guner, et al.
Published: (2021-03-01)

Rational use of chloroquine and hydroxychloroquine in times of COVID-19
by: Rosa Camila Lucchetta, et al.
Published: (2020-04-01)

Proarrhythmic effects of chloroquine and hydroxychloroquine in the context of Covid-19
by: Carlos Enrique Salgado-Fuentes
Published: (2021-05-01)

More gastro-intestinal adverse events in non-ICU hospitalised COVID-19 patients treated with chloroquine versus hydroxychloroquine
by: S. Verheijen, et al.
Published: (2021-02-01)

Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine
by: David M. Stevens, et al.
Published: (2021-12-01)

The Rise and Fall of Chloroquine/Hydroxychloroquine as Compassionate Therapy of COVID-19
by: Elangovan Manivannan, et al.
Published: (2021-05-01)

Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine
by: Babayeva M, et al.
Published: (2020-10-01)

Hydroxychloroquine and chloroquine in prophylaxis and treatment of COVID-19: What is known?
by: Pathiyil Ravi Shankar, et al.
Published: (2021-01-01)

Hydroxychloroquine and chloroquine for COVID-19: psychiatric aspects of patient safety considerations
by: Partha Sarathi Biswas, et al.
Published: (2020-09-01)

Caution of retinal toxicity using chloroquine and hydroxychloroquine in the treatment of COVID-19
by: Li-Yuan Wang, et al.
Published: (2020-07-01)

Oxidative Stress, Proton Fluxes, and Chloroquine/Hydroxychloroquine Treatment for COVID-19
by: Christina B. Klouda, et al.
Published: (2020-09-01)

Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine
by: Vincent Gies, et al.
Published: (2020-07-01)

Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management
by: Jacob A. Lebin, et al.
Published: (2020-07-01)

Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis
by: Liu D, et al.
Published: (2018-06-01)

Systematic review and meta-analysis of efficacy and safety of hydroxychloroquine and chloroquine in the treatment of COVID-19
by: Niti Mittal, et al.
Published: (2021-01-01)

Chloroquine, hydroxychloroquine, and COVID-19: Systematic review and narrative synthesis of efficacy and safety
by: Michael Takla, et al.
Published: (2020-12-01)

Research Progress of Chloroquine and Hydroxychloroquine on the COVID-19 and Their Potential Risks in Clinic Use
by: Yan Chen, et al.
Published: (2020-07-01)

Chloroquine and hydroxychloroquine repositioning in times of COVID-19 pandemics, all that glitters is not gold
by: Francisco José Roma Paumgartten, et al.

Review on the global epidemiological situation and the efficacy of chloroquine and hydroxychloroquine for the treatment of COVID-19
by: S. Saqrane, et al.
Published: (2020-05-01)

Should chloroquine and hydroxychloroquine be used to treat COVID-19? A rapid review
by: Kome Gbinigie, et al.
Published: (2020-04-01)

Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine
by: Bianza Moise Bakadia, et al.
Published: (2021-01-01)

Impact of hydroxychloroquine on disease progression and ICU admissions in patients with SARS-CoV-2 infection
by: Awad, N., et al.
Published: (2021)

Chloroquine and Hydroxychloroquine Myopathy: Clinical Spectrum and Treatment Outcomes
by: Elie Naddaf, et al.
Published: (2021-02-01)

CHLOROQUINE AND HYDROXYCHLOROQUINE: POTENTIALLY INAPPROPRIATE MEDICATIONS FOR OLDER ADULTS?
by: Milton Gorzoni
Published: (2021-02-01)

The mechanism of chloroquine/hydroxychloroquine and its application in stomatological diseases
by: LIN Lin, et al.
Published: (2021-03-01)

Hydroxychloroquine/chloroquine in patients with COVID-19 in Wuhan, China: a retrospective cohort study
by: Zhe Chen, et al.
Published: (2021-08-01)

Chloroquine and hydroxychloroquine as a repurposed agent against COVID-19: a narrative review
by: Yogesh Acharya, et al.
Published: (2020-08-01)

COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology.
by: Nicholas J White, et al.
Published: (2020-09-01)

Computational Studies of Hydroxychloroquine and Chloroquine Metabolites as Possible Candidates for Coronavirus (COVID-19) Treatment
by: Niteen A. Vaidya, et al.
Published: (2020-11-01)

Use of hydroxychloroquine and chloroquine in COVID-19: How good is the quality of randomized controlled trials?
by: Faizan Mazhar, et al.
Published: (2020-12-01)

Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given
by: Amit Malviya
Published: (2020-03-01)

Clinical Implications of Chloroquine and Hydroxychloroquine Ototoxicity for COVID-19 Treatment: A Mini-Review
by: Pattarawadee Prayuenyong, et al.
Published: (2020-05-01)

Cannot write session to /tmp/vufind_sessions/sess_1uuknvi7l1rvih27p4bsd48jlv